Insider buying · SEC Form 4

Insider Buying — May 5, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

2insider buys
$592Kbought in total
1company
2by CEOs, CFOs and other chiefs
OPCHlargest: $327K

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
OPCHOption Care Health, Inc.Meenal SethnaCFO$327K16,225$20.15AddedMay 4, 2026
Form 4 ↗
Post-Q1 2026 earnings cluster buy; OPCH fell ~26% on Apr 30 after revenue miss and guidance cut. CFO bought 16,225 shares at $19.94–$20.38 (wtd avg $20.1587); now $21.14, +4.9% above buy price. Adds to existing 82,112-share position; now holds 98,337 shares directly.
OPCHOption Care Health, Inc.John Charles RademacherCEO$265K12,500$21.18AddedMay 4, 2026
Form 4 ↗
Post-Q1 2026 earnings cluster buy; same day as CFO purchase. CEO bought 12,500 shares at $21.14–$21.18 (wtd avg $21.1765); now $21.14, -0.2% vs buy price. Adds to existing 682,652-share position; now holds 695,152 shares directly.

AIThe day in insider buying

SEC Form 4 Insider Scan — May 5, 2026

Scanned the last 24 hours of EDGAR Form 4 filings. 2 qualifying buys (≥ $250K, transaction type P) totalling $591,630.

Both purchases come from the same company — Option Care Health (OPCH) — in a striking post-earnings cluster buy. OPCH fell roughly 26% on April 30 after missing Q1 2026 revenue estimates by 3.3% and cutting full-year guidance. Four days later, the CEO and CFO stepped in together on the open market.

Headline filings

  • OPCH — Meenal Sethna (CFO) bought 16,225 shares ≈ $326,924 at $20.1587 avg (range $19.94–$20.38); now $21.14 (+4.9% since buy). (filing)
  • OPCH — John Charles Rademacher (CEO) bought 12,500 shares ≈ $264,706 at $21.1765 avg (range $21.14–$21.18); now $21.14 (-0.2% since buy). (filing)

Notes

Cluster buy / post-earnings conviction. OPCH reported Q1 2026 on April 30: revenue of $1.35B missed the $1.40B consensus (-3.3%), though EPS beat ($0.40 vs $0.37 est). Management cut FY2026 revenue guidance to $5.73B midpoint, ~3.6% below consensus. The stock plunged ~26% on the news. Both C-suite insiders used the first open post-earnings trading window (approximately May 1–5) to buy at current levels, signalling conviction that the sell-off was overdone. The CFO's buy at $19.94–$20.38 has already moved +4.9% higher; the CEO's $21.14–$21.18 lot is fractionally underwater at $21.14. Post-earnings insider buying by two senior executives simultaneously is historically one of the strongest bullish signals in Form 4 analysis. No other open-market purchases filed in the last 24 hours cleared the $250K threshold.

Most-bought stocks, last 30 days

  • CHTR $6.57M · 6 buys, 3 insidersCharter Communications, Inc.
  • SPMC $6.00M · 1 buySound Point Meridian Capital, Inc.
  • IPX $5.14M · 4 buys, 2 insidersIperionX Limited
  • SPGI $998K · 1 buyS&P Global Inc.
  • TXT $989K · 1 buyTextron Inc.
  • OPCH $592K · 2 buys, 2 insidersOption Care Health, Inc.
  • SON $340K · 1 buySonoco Products Company
  • IP $313K · 1 buyInternational Paper Co.

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.